racemethionine has been researched along with Breast Neoplasms in 5 studies
Racemethionine: A preparation of METHIONINE that includes a mixture of D-methionine and L-methionine isomers.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluates the associations between dietary intakes and circulating blood levels of methionine, choline or betaine and breast cancer risk, which remains currently unclear." | 9.41 | The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. ( De Bacquer, D; Dimou, N; Godderis, L; Huybrechts, I; Indave Ruiz, BI; Katsikari, A; Van Puyvelde, H, 2023) |
| " The aim of the present study was to determine the efficacy of methionine restriction with rMETase and a low-methionine diet combined with first-line neo-adjuvant chemotherapy, in a patient with metastatic ILC of the breast." | 5.72 | Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction. ( Aoki, Y; Hamada, K; Han, Q; Hoffman, RM; Hozumi, C; Kubota, Y; Masaki, N; Obara, K; Tsunoda, T, 2022) |
| "This study evaluates the associations between dietary intakes and circulating blood levels of methionine, choline or betaine and breast cancer risk, which remains currently unclear." | 5.41 | The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. ( De Bacquer, D; Dimou, N; Godderis, L; Huybrechts, I; Indave Ruiz, BI; Katsikari, A; Van Puyvelde, H, 2023) |
| " The aim of the present study was to determine the efficacy of methionine restriction with rMETase and a low-methionine diet combined with first-line neo-adjuvant chemotherapy, in a patient with metastatic ILC of the breast." | 1.72 | Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction. ( Aoki, Y; Hamada, K; Han, Q; Hoffman, RM; Hozumi, C; Kubota, Y; Masaki, N; Obara, K; Tsunoda, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubota, Y | 3 |
| Han, Q | 3 |
| Masaki, N | 3 |
| Hozumi, C | 3 |
| Hamada, K | 3 |
| Aoki, Y | 3 |
| Obara, K | 3 |
| Tsunoda, T | 3 |
| Hoffman, RM | 3 |
| Gonzalez-Valero, A | 2 |
| Reeves, AG | 2 |
| Page, ACS | 2 |
| Moon, PJ | 2 |
| Miller, E | 2 |
| Coulonval, K | 2 |
| Crossley, SWM | 2 |
| Xie, X | 2 |
| He, D | 2 |
| Musacchio, PZ | 2 |
| Christian, AH | 2 |
| McKenna, JM | 2 |
| Lewis, RA | 2 |
| Fang, E | 2 |
| Dovala, D | 2 |
| Lu, Y | 2 |
| McGregor, LM | 2 |
| Schirle, M | 2 |
| Tallarico, JA | 2 |
| Roger, PP | 2 |
| Toste, FD | 2 |
| Chang, CJ | 2 |
| Van Puyvelde, H | 1 |
| Dimou, N | 1 |
| Katsikari, A | 1 |
| Indave Ruiz, BI | 1 |
| Godderis, L | 1 |
| Huybrechts, I | 1 |
| De Bacquer, D | 1 |
| Pankevičiūtė-Bukauskienė, M | 1 |
| Mikalayeva, V | 1 |
| Žvikas, V | 1 |
| Skeberdis, VA | 1 |
| Bordel, S | 1 |
| Liu, F | 1 |
| Zhou, H | 1 |
| Peng, Y | 1 |
| Qiao, Y | 1 |
| Wang, P | 1 |
| Si, C | 1 |
| Wang, X | 1 |
| Gong, J | 1 |
| Chen, K | 1 |
| Song, F | 1 |
1 review available for racemethionine and Breast Neoplasms
| Article | Year |
|---|---|
The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis.
Topics: Betaine; Breast Neoplasms; Choline; Eating; Female; Humans; Methionine; Prospective Studies; Racemet | 2023 |
4 other studies available for racemethionine and Breast Neoplasms
| Article | Year |
|---|---|
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction.
Topics: Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Lymph Nodes; Lymphatic M | 2022 |
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction.
Topics: Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Lymph Nodes; Lymphatic M | 2022 |
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction.
Topics: Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Lymph Nodes; Lymphatic M | 2022 |
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction.
Topics: Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Lymph Nodes; Lymphatic M | 2022 |
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Humans; Ligands; Methionine; Oxidation-Reductio | 2022 |
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Humans; Ligands; Methionine; Oxidation-Reductio | 2022 |
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Humans; Ligands; Methionine; Oxidation-Reductio | 2022 |
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Humans; Ligands; Methionine; Oxidation-Reductio | 2022 |
Multi-Omics Analysis Revealed Increased De Novo Synthesis of Serine and Lower Activity of the Methionine Cycle in Breast Cancer Cell Lines.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Methionine; Multiomics; Racemethion | 2023 |
Plasma One-Carbon Metabolism-Related Micronutrients and the Risk of Breast Cancer: Involvement of DNA Methylation.
Topics: Breast Neoplasms; Carbon; Case-Control Studies; Choline; Cysteine; DNA Methylation; Female; Folic Ac | 2023 |